Form 4: Revolution Medicines CFO Sells Shares
Insider Transaction (Form 4)
Jack Anders, Chief Financial Officer of Revolution Medicines, Inc., sold 4,053 shares of common stock on September 16, 2026.
Summary
- Open-market sale: disposed of 61 Common Stock at $195.00 ($11,895) on September 16, 2026; holds 123,208 after (Direct).
- Open-market sale: disposed of 3,992 Common Stock at $199.30 ($795,618) on September 16, 2026; holds 119,216 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $807,513 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jack Anders — Officer (Chief Financial Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-16 | Open-market sale | Common Stock | 61 | $195 | $11.9K | 123,208 |
| 2026-09-16 | Open-market sale | Common Stock | 3,992 | $199 | $795.6K | 119,216 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-16 | Open-market sale (61 shares) |
| 2026-09-16 | Open-market sale (3,992 shares) |
Keywords
insider transaction, Form 4, RVMD, Revolution Medicines, Inc., bearish, Jack Anders
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.